January 5, 2023 January 5, 2023Categories Trial ResultsTrial Results: The TAILORx trial continues to provide reassurance that many women with early breast cancer can safely forego chemotherapyThe TAILORx trial in over 10,000 women with early breast cancer reaches 12 years of recurrence and survival outcomes
September 26, 2022 September 26, 2022Categories EditorialsFor people with stage 4 cancer, survivorship is complicatedRobin Evans, a research advocate with the ECOG-ACRIN Cancer Research Group, shares her perspective on navigating the survivorship community as someone living with stage 4 cancer
September 26, 2022 September 26, 2022Categories Trial ResultsTrial Results: ECOG-ACRIN research round-up – Fall 2022Summaries of recently reported ECOG-ACRIN research results
June 28, 2022 June 28, 2022Categories EditorialsUnconscious bias among physicians creates obstacles to genetic counseling and testing for Black women with breast cancerA nationwide survey found that doctors’ beliefs and practices regarding genetic counseling and testing varied by race